Congratulations to Professor Arnon on her successful Wellcome Trust Investigator Award entitled: \u201cSpatiotemporal basis of adaptive immunity in the spleen.\u201d
NDORMS and GRAPPA (the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis) have launched Informatree, a new web resource to help people living with Psoriatic Arthritis.
A new study published in JAMA, has found that a drug recently licensed in the UK has no effect on post-operative knee replacement recovery or pain, compared to the current treatment when administered at site of surgery.
By studying blood vessels at single cell resolution, Professor Jagdeep Nanchahal and colleagues found that in Dupuytren\u2019s disease, a fibrotic disorder of the hand, the vasculature is key to orchestrating the development of human fibrosis.
Research from the Botnar Institute for Musculoskeletal Sciences shows that Artificial intelligence (AI) is an effective tool for fracture detection that has potential to aid clinicians in busy emergency departments.
Researchers at the Kennedy Institute of Rheumatology have used 3D and live-imaging to show how resident memory B cells boost antibodies to fight influenza.
The COVID-19 Multi-omic Blood Atlas (COMBAT) has identified blood hallmarks of COVID-19 involving particular immune cell populations and their development, components of innate and adaptive immunity, and connectivity with the inflammatory response.
NDORMS Professor of Musculoskeletal and Surgical Science, David Beard, has been named National Institute of Health Research (NIHR) Senior Investigator.
Professors Matthew Higgins and Michael Dustin from the University of Oxford, Prof Gavin Wright from the University of York, and Professors Shiroh Iwanaga and Hisashi Arase from Osaka University have secured a Wellcome Collaborative Award for their study \u201cHow do RIFINs and STEVORs modulate human immunity during malaria?\u201d
A new collaboration between Oxford, Brazil and Pakistan has been funded by the Bill & Melinda Gates Foundation. The partnership will provide researchers with de-identified health data from two of the worlds global COVID-19 hotspots to increase understanding of COVID-19 in these communities and help accelerate the management of the disease.
Interrogating metabolic crosstalk in the tumour-bone microenvironment, new research from the Edwards group shows how the pentose phosphate pathway contributes to prostate cancer bone metastasis.
Oxford is one of 28 sites that will benefit from over \u00a3160 million awarded over five years to expand early phase clinical research for the benefit of NHS patients.
People are at the heart of NDORMS and as such the department is dedicated to fostering an inclusive and supportive culture for all its staff and students. Two new initiatives have been recently launched; the mediation service, and a mental health first aiders programme.
The European Medicines Agency has announced the establishment of the Data Analysis and Real World Interrogation Network (DARWIN EU\u00ae) to support better decision making on the development and effectiveness of medicines and vaccines.
![\"Tal](\"https://www.ndorms.ox.ac.uk/news/wellcome-trust-investigator-award-for-professor-arnon/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n